Sidley Advises Pivotal bioVenture Partners China and Frazier Healthcare Partners in Formation of SanReno Therapeutics with Chinook Therapeutics

Dec 13, 2021

Posted by Sidley Austin

Sidley advised Pivotal bioVenture Partners China (Pivotal), a leading venture capital fund in the field of life sciences, and Frazier Healthcare Partners (Frazier), a leading provider of growth and venture capital to healthcare companies, in the formation of SanReno Therapeutics (SanReno), a joint venture with Chinook Therapeutics, Inc. (Nasdaq: KDNY) (Chinook), a biopharmaceutical company focused on the discovery, development, and commercialization of precision medicines for kidney diseases, and the equity investment in SanReno. Continue reading

See all Member News